MicroPort<sup>®</sup> Attends AsiaPCR 2017

Singapore - Shanghai MicroPort Medical (Group) Co., Ltd. ("MicroPort®") recently attended AsiaPCR 2017 held in Singapore. During the premier cardiovascular course in Asia that gathered renowned cardiovascular professionals from Asian countries including Singapore, China, Japan, South Korea, Malaysia and Thailand, MicroPort® displayed its new-generation drug-eluting stent Firehawk® Rapamycin Target Eluting Coronary Stent System ("Firehawk®"), the upgraded balloon dilatation catheter Firefighter™ PTCA Balloon Dilatation Catheter ("Firefighter™") and some PCI accessories in its booth, which attracted many attendees to inquire for product information.
 
During the congress, AsiaPCR Chairman William Wijns visited MicroPort® booth and held cordial talks with Dr. Linda Lin, First Vice President of MicroPort® International Business. As the brand image of MicroPort® is gaining higher recognition among Indian surgeons with its market expansion in the India market, several Indian professionals, such as Professor Upendra Kaul of Escorts Heart Institute, were attracted to visit MicroPort® booth. MicroPort® staff also received experts from Pakistan, Malaysia, the Philippines, Thailand and European countries, which will further enhance the mutual communications between MicroPort® and the international cardiovascular interventional specialists, paving the way for its international business development.
 
In the AsiaPCR, MicroPort® demonstrated the excellent performance and development potential of its innovative products to the people in attendance. In particular, we hope to take advantage of this congress to promote Firehawk® and Firefighter™ in the Asia markets to provide better solutions for patients.